Oncolytic Activity of the Vaccine Strain of Type 3 Poliovirus on the Model of Rat Glioma C6 Cells

Bull Exp Biol Med. 2019 May;167(1):111-115. doi: 10.1007/s10517-019-04472-6. Epub 2019 Jun 8.

Abstract

Rat glioma cell line C6 expressing human poliovirus receptor (PVR) and susceptible to polioviruses (C6-PVR-BFP) was used to produce a clone with knockout of IFNα/β (Ifnar1) receptor subunit 1 gene (Ifnar1). The sensitivity of C6-PVR-BFP cells to the vaccine strain of poliovirus type 3 (PV3) depended on the signaling pathways of the cell response to type 1 IFN. Using the model of subcutaneous tumor xenografts, we demonstrated oncolytic activity of PV3 against C6-PVR-BFP cells that depended on the expression of PVR and increased considerably upon disturbances in IFN response pathways.

Keywords: interferon; oncolytic viruses; poliovirus; poliovirus receptor; virotherapy.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Glioma / metabolism
  • Glioma / therapy*
  • Glioma / virology*
  • Interferon-alpha / genetics
  • Interferon-beta / genetics
  • Mice
  • Oncolytic Virotherapy / methods*
  • Oncolytic Viruses / physiology
  • Poliovirus / physiology*
  • Rats
  • Rats, Mutant Strains
  • Receptor, Interferon alpha-beta / genetics
  • Receptor, Interferon alpha-beta / metabolism

Substances

  • Interferon-alpha
  • Receptor, Interferon alpha-beta
  • Interferon-beta